2021 Revenues ($USD) : $8,434,000,000
2021 R&D spend : $465,000,000
2021 Number of Employees : 19,600
Fiscal Year End : 12/31/2021
Leader : CEO Joseph C. Papa

Bausch Health sells a range of dermatology, neurology, and infectious disease therapies. Its Salix segment offers GI products in the U.S. The company also offers a variety of medical-device and over-the-counter products focused especially on eye health, gastroenterology and dermatology. The company has proposed spinning out its Bausch + Lomb vision care division, although several institutional investors are seeking to legally block the planned spinoff. Those investors have pursued litigation with Bausch, which was known as Valeant Pharmaceuticals until 2016. —BB